1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Specialties
Bruker Corporation

Bruker Corporation

BRKRP
Bruker CorporationUS flagNASDAQ
445.25
USD
+0.51
- -
9.20BMarket Cap

Total Valuation

Bruker Corporation carries a market capitalization of 9.20B, placing it among publicly traded companies globally. Its enterprise value stands at 1.59B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap9.20B
Enterprise Value1.59B

Share Statistics

Bruker Corporation currently has 152.22M shares outstanding.

Shares Outstanding152.22M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Enterprise Valuation

On an enterprise value basis, Bruker Corporation trades at an EV/EBITDA multiple of 3.64 and an EV/FCF ratio of 7.38. The EV/Sales ratio of 0.46 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 7.60 provides insight into valuation relative to core operating earnings.

EV / Sales0.46
EV / EBITDA3.64
EV / EBIT7.60
EV / FCF7.38

Financial Position

Bruker Corporation maintains a current ratio of 1.55, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 66.78, indicating elevated leverage, while an interest coverage ratio of 7.37 demonstrates adequate ability to service its debt obligations.

Current Ratio1.55
Quick Ratio0.65
Debt / Equity66.78
Debt / EBITDA3.82
Interest Coverage7.37

Financial Efficiency

Bruker Corporation posts a return on equity of -1.52 and a return on invested capital of -1.18.

Return on Equity (ROE)-1.52
Return on Assets (ROA)-0.19
Return on Invested Capital (ROIC)-1.18
Return on Capital Employed (ROCE)-0.63
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.69

Taxes

Over the trailing twelve months, Bruker Corporation has paid 23.10M in income taxes, reflecting an effective tax rate of 122.87.

Income Tax23.10M
Effective Tax Rate122.87

Stock Price Statistics

Bruker Corporation's stock has gained approximately 77.74451% over the past 52 weeks. The 50-day moving average sits at 411.04, while the 200-day moving average is 347.44.

Beta (5Y)N/A
52-Week Price Change77.74451%
50-Day Moving Average411.04
200-Day Moving Average347.44
Average Volume (20 Days)N/A

Income Statement

EBITDA reached 437.70M, while operating income came in at 209.50M.

Revenue3.46B
Gross Profit1.57B
Operating Income209.50M
Pretax Income18.80M
Net Income-11.60M
EBITDA437.70M
EBIT209.50M
Earnings Per Share (EPS)N/A

Balance Sheet

Bruker Corporation holds 133.40M in cash and equivalents against 1.67B in total debt, resulting in a net debt position of 1.54B. Total book value stands at 2.36B, with working capital of 748.50M providing operational flexibility.

Cash & Cash Equivalents133.40M
Total Debt1.67B
Net Debt1.54B
Equity (Book Value)2.36B
Book Value Per ShareN/A
Working Capital748.50M

Cash Flow

Bruker Corporation produced 140.30M in operating cash flow over the past twelve months.

Operating Cash Flow140.30M
Capital Expenditures-89.00M
Free Cash Flow51.30M
FCF Per ShareN/A

Margins

Bruker Corporation operates with a gross margin of 45.29, reflecting its pricing power and cost economics. The operating margin of 6.06 and net profit margin of -0.34 provide insight into operational efficiency.

Gross Margin45.29
Operating Margin6.06
Pretax Margin0.54
Profit Margin-0.34
EBITDA Margin12.66

Dividends & Yields

The company's payout ratio of -59.37 indicates the proportion of earnings distributed to shareholders.

Dividend Per ShareN/A
Dividend YieldN/A
Payout Ratio-59.37
Shareholder YieldN/A
FCF YieldN/A

Scores

Bruker Corporation posts an Altman Z-Score of 2.28, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.28